leflunomide has been researched along with Bone Neoplasms in 1 studies
Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.
Bone Neoplasms: Tumors or cancer located in bone tissue or specific BONES.
Excerpt | Relevance | Reference |
---|---|---|
"Treatment with leflunomide, a potent activator of mitochondrial fusion proteins, overcame inhibitory effects of fission on migration, signaling, and metastasis." | 1.56 | Enhanced mitochondrial fission suppresses signaling and metastasis in triple-negative breast cancer. ( Bevoor, A; Boppisetti, J; Buschhaus, JM; Chen, YC; Chiang, B; Cutter, AC; Eckley, S; Ghosh, P; Haley, HR; Humphries, BA; Lahann, J; Luker, GD; Luker, KE; Neale, DB; Palagama, DSW; Qyli, T; Robison, TH; Ross, BD; Sahoo, D; Sahoo, S; Spinosa, PC; Yoon, E, 2020) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Humphries, BA | 1 |
Cutter, AC | 1 |
Buschhaus, JM | 1 |
Chen, YC | 1 |
Qyli, T | 1 |
Palagama, DSW | 1 |
Eckley, S | 1 |
Robison, TH | 1 |
Bevoor, A | 1 |
Chiang, B | 1 |
Haley, HR | 1 |
Sahoo, S | 1 |
Spinosa, PC | 1 |
Neale, DB | 1 |
Boppisetti, J | 1 |
Sahoo, D | 1 |
Ghosh, P | 1 |
Lahann, J | 1 |
Ross, BD | 1 |
Yoon, E | 1 |
Luker, KE | 1 |
Luker, GD | 1 |
1 other study available for leflunomide and Bone Neoplasms
Article | Year |
---|---|
Enhanced mitochondrial fission suppresses signaling and metastasis in triple-negative breast cancer.
Topics: Animals; Bone Neoplasms; Carboxy-Lyases; Cell Transformation, Neoplastic; Female; Humans; Immunosupp | 2020 |